FINANCIALS

NAMSW Newamsterdam Pharma Co Nv 1936258

Income Statement
Revenue	nams-20240930	29,111,000
Net Income	nams-20240930	-16,647,000
Profit Margin		-57.18%

Balance Sheet
Current Assets	437,874,000
Assets	439,191,000
Current Liabilities	41,255,000
Liabilities	60,329,000
Equity	378,862,000

Cash Flow Statement
Operating Cash Flow	-121,083,000
Investing Cash Flow	-669,000

Market Analysis
Price	12.50
BVPS	324.28
PB	0.04
PS	0.03
FCF	-121,752,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view NAMSW documents filed with the SEC.

NAMSW Filings Clear

View A List of Tickers